FIB and AFU are significant diagnoses for prostate cancer, but they cannot be used as effectively as SA for diagnosing PCa and CSPCa with PSA between 4.0 and 20.0 ng/mL. The gene discussed is KLK3; the disease is posterior cortical atrophy.